Celestica Inc. (CLS) Down 5.1% — Should I Scale Back Here?

  • CLS fell 5.06% to $301.32 from $317.38 the previous trading day
  • Weiss Ratings assigns B- (Buy)
  • Market cap is $36.41B

Celestica Inc. (CLS) gave back meaningful ground on Friday, sliding 5.06% and shedding $16.06 to close at $301.32 on the NYSE. The retreat comes after a significant run-up that had pushed shares as high as $474.03 on June 2, 2026 — a 52-week peak the stock now sits roughly 36% below. That gap from the high underscores just how much of a correction has unfolded since early summer, and today's session added another uncomfortable layer to an already extended pullback.

Volume came in at approximately 1.04 million shares, well short of the 90-day average of around 2.41 million. The subdued turnover suggests this was not a panic-driven flush but rather a relatively orderly decline on thin participation. Still, below-average volume on a down day does not rule out further selling — it simply means conviction on both sides was muted heading into the weekend.


Why Celestica Inc. Price is Moving Lower

Today's decline most likely reflects a post-earnings valuation pullback and profit-taking rather than any fresh operating failure — and that distinction matters. Celestica's Q2 2026 results, reported on July 28, were genuinely strong: adjusted EPS of $2.54 beat the $2.29 consensus by a meaningful margin, and revenue of $4.68 billion cleared the roughly $4.45 billion estimate while registering a striking 62.4% increase year over year. Management followed through with a raised full-year 2026 outlook, lifting guidance to approximately $20.5 billion in revenue and $11.30 in adjusted EPS. That combination would normally sustain a rally — but when a stock has already run hard into a print, even a strong beat can trigger a "sell the news" unwind as traders lock in gains.

That dynamic was already visible heading into this week. By August 21, shares were trading around $296 and had climbed back toward that level before today's slip, yet they remained well below the Street's average price target of approximately $438.86 — a spread that reflects how aggressively the stock had been bid up during its earlier surge. Adding to the supply pressure, a $3 billion common stock offering announced around August 5 to help fund AI infrastructure buildout diluted the shareholder base and introduced a meaningful overhang. Equity offerings of that size signal ambitious growth plans, but they also reset the price ceiling in the near term as the market absorbs new shares. Together, the post-guidance exhaustion, the dilutive offering, and the wide gap between current levels and the June high create a backdrop where further consolidation remains entirely plausible.


What is the Celestica Inc. Rating - Should I Sell?

Weiss Ratings assigns CLS a B- rating. Current recommendation is Buy.

The B- rating is anchored by a set of sub-index scores that reflect a business firing on multiple cylinders operationally. Revenue growth of 62.39% earns the Excellent Growth Index — a rare top-line expansion rate even by the aggressive standards of AI-driven infrastructure spending, and one that signals Celestica is capturing a disproportionate share of the buildout cycle. ROE of 52.69% earns the Excellent Efficiency Index — a standout figure for an electronics manufacturing services provider operating in a capital-intensive, margin-compressed industry where most peers struggle to generate returns anywhere near that level. Rounding out the balance sheet picture, the Excellent Solvency Index suggests the company's financial structure remains sound even as it pursues large-scale investment, including the $3 billion stock offering.

Profit margin at 7.15% is respectable for a contract manufacturer but is worth monitoring, particularly as competitive pricing pressures and rising input costs persist across the hardware supply chain. The Fair Total Return Index and Fair Volatility Index carry their own implications: total return has been uneven despite the operational strength, and the volatility reading is a candid acknowledgment that CLS can move sharply in either direction — as today's session demonstrated. A forward P/E of 33.01 is not extreme given the growth trajectory, but it leaves limited room for disappointment if execution stumbles or AI infrastructure spending softens.

Within the Information Technology sector, Celestica sits alongside Sandisk Corporation (SNDK, B-), while ranking a step below Apple Inc. (AAPL, B), Cisco Systems, Inc. (CSCO, B), Dell Technologies Inc. (DELL, B), and Amphenol Corporation (APH, B). That relative positioning suggests Celestica's fundamentals support a Buy thesis, but the modifier matters — the B- signals a slightly higher risk profile than the straight-B peers, consistent with the stock's elevated volatility and the near-term supply overhang from the equity offering.


About Celestica Inc.

Celestica Inc. (CLS) is an Information Technology company that provides end-to-end supply chain solutions, design services, and advanced manufacturing for some of the most demanding technology markets in the world. The company partners with original equipment manufacturers and hyperscale technology companies to engineer and produce complex hardware spanning communications infrastructure, enterprise computing, and AI accelerator platforms — markets that have become central to the global buildout of next-generation data centers and cloud capacity.

Celestica's capabilities extend well beyond simple contract assembly. The company offers integrated design, engineering, supply chain management, and after-market services — a full-lifecycle value proposition that deepens customer relationships and creates switching costs that pure assemblers cannot match. Its hardware platforms segment, which includes servers, storage systems, and networking equipment purpose-built for high-performance computing environments, has been a primary driver of the company's dramatic revenue acceleration. Celestica also serves the aerospace and defense sector with ruggedized electronics solutions, adding a degree of business mix diversification outside the cyclical consumer and enterprise technology markets.

The company's competitive positioning is reinforced by its long-standing relationships with major technology customers, its global manufacturing footprint, and its growing expertise in thermal management and high-density interconnect technologies — increasingly critical as AI workloads push the physical limits of conventional server and rack designs. Those proprietary capabilities, combined with management's willingness to invest aggressively in capacity ahead of demand, form the strategic rationale behind the recent $3 billion capital raise and position Celestica to remain a key infrastructure partner as AI hardware requirements continue to scale.


Investor Outlook

Celestica Inc. (CLS) carries a Weiss Rating of B- (Buy), but the near-term picture calls for patience rather than urgency — the combination of post-earnings profit-taking, share dilution from the August offering, and a stock sitting 36% off its June high suggests the path back toward the Street's $438.86 average target will not be linear. Investors should watch for stabilization in trading volumes, any updates to full-year 2026 guidance as the year progresses, and broader sentiment shifts around AI infrastructure spending that could either reignite the rally or deepen the consolidation. See full rankings of all B--rated Information Technology stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $217.55
B
AAPL NASDAQ $319.70
B
AVGO NASDAQ $368.79
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $103.09
Top Financial Stocks
See All »
B
B
JPM NYSE $357.62
B
V NYSE $381.60
Top Health Care Stocks
See All »
B
LLY NYSE $1,174.61
B
JNJ NYSE $268.04
B
ABBV NYSE $255.48
Top Real Estate Stocks
See All »
B
PLD NYSE $140.70
B
EQIX NASDAQ $1,044.41